About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Htr2ctm1Knk
targeted mutation 1, Kazuko Nishikura
MGI:3823041
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Htr2ctm1Knk/Htr2ctm1Knk B6.Cg-Htr2ctm1Knk MGI:3823071
hm2
Htr2ctm1Knk/Htr2ctm1Knk C.Cg-Htr2ctm1Knk MGI:3823070
ht3
Htr2ctm1Knk/Htr2c+ B6.Cg-Htr2ctm1Knk MGI:3823076
ht4
Htr2ctm1Knk/Htr2ctm2Knk B6.Cg-Htr2ctm1Knk/Htr2ctm2Knk MGI:3823077
cx5
Htr2ctm1Knk/Y
Mc4rtm1Lowl/Mc4rtm1Lowl
involves: 129S4/SvJae * C57BL/6 MGI:3823073
ot6
Htr2ctm1Knk/Y B6.Cg-Htr2ctm1Knk MGI:3823072
ot7
Htr2ctm1Knk/Y C.Cg-Htr2ctm1Knk MGI:3823069


Genotype
MGI:3823071
hm1
Allelic
Composition
Htr2ctm1Knk/Htr2ctm1Knk
Genetic
Background
B6.Cg-Htr2ctm1Knk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Htr2ctm1Knk mutation (1 available); any Htr2c mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• less than 20% of mice survive the postnatal period
• however, removal of competing wild-type and female heterozygous littermates increases survival to 80%

growth/size/body
• despite normal birth weights, mice exhibit a 50% reduction in body weight gain compared to wild-type mice regardless of strain background or fostering with wild-type mothers
• however, between 3 and 5 weeks of age growth rates are normal
• mice exhibit decreased body length compared to wild-type mice but this difference becomes less significant after weaning




Genotype
MGI:3823070
hm2
Allelic
Composition
Htr2ctm1Knk/Htr2ctm1Knk
Genetic
Background
C.Cg-Htr2ctm1Knk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Htr2ctm1Knk mutation (1 available); any Htr2c mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• despite normal birth weights, mice exhibit a 50% reduction in body weight gain compared to wild-type mice regardless of strain background or fostering with wild-type mothers




Genotype
MGI:3823076
ht3
Allelic
Composition
Htr2ctm1Knk/Htr2c+
Genetic
Background
B6.Cg-Htr2ctm1Knk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Htr2ctm1Knk mutation (1 available); any Htr2c mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body




Genotype
MGI:3823077
ht4
Allelic
Composition
Htr2ctm1Knk/Htr2ctm2Knk
Genetic
Background
B6.Cg-Htr2ctm1Knk/Htr2ctm2Knk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Htr2ctm1Knk mutation (1 available); any Htr2c mutation (13 available)
Htr2ctm2Knk mutation (1 available); any Htr2c mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body




Genotype
MGI:3823073
cx5
Allelic
Composition
Htr2ctm1Knk/Y
Mc4rtm1Lowl/Mc4rtm1Lowl
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Htr2ctm1Knk mutation (1 available); any Htr2c mutation (13 available)
Mc4rtm1Lowl mutation (2 available); any Mc4r mutation (48 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• mice exhibit hyperphagia

growth/size/body
N
• unlike when either gene is knocked-out, mice exhibit normal growth rates
• at 6 weeks but not 16 weeks




Genotype
MGI:3823072
ot6
Allelic
Composition
Htr2ctm1Knk/Y
Genetic
Background
B6.Cg-Htr2ctm1Knk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Htr2ctm1Knk mutation (1 available); any Htr2c mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice exhibit convulsions and death at a dose of MK212 (a HTR2C-selective agonist) that is 100 times lower than in wild-type mice
• less than 20% of mice survive the postnatal period
• however, removal of competing wild-type and female heterozygous littermates increases survival to 80%

homeostasis/metabolism
N
• despite decreased growth, mice exhibit normal levels of thyroxine and corticosterone
• at 3 weeks but not 6 weeks
• at 3 weeks, circulating ghrelin levels are higher than in wild-type mice
• however, by 6 weeks circulating ghrelin levels are normal
• at 3 weeks, circulating leptin levels are lower than in wild-type mice
• however, leptin levels are normal at 6 weeks
• mice exhibit more prominent hypothermia than wild-type mice in response to 8-OH-DPAT (a HTR1A-specific agonist)
• however, untreated mice exhibit normal body temperature
• unlike in wild-type mice, metabolic rate is not increased by treatment with CL316243 (a beta-adrenergic-specific agonist)
• mice exhibit a 40% increase in basal metabolic rate compared to in wild-type mice
• treatment with SB242084 reduces energy expenditure but it remains higher than in wild-type mice
• mice exhibit convulsions and death at a dose of MK212 (a HTR2C-selective agonist) that is 100 times lower than in wild-type mice
• mice exhibit more prominent hypothermia than wild-type mice in response to 8-OH-DPAT (a HTR1A-specific agonist)
• mice exhibit convulsions and death at a dose of MK212 (a HTR2C-selective agonist) that is 100 times lower than in wild-type mice
• mice exhibit increased sensitivity to mCPP and Ro60-0174, HTR2C-selective agonists

growth/size/body
• adipose accumulation is lower than in wild-type mice
• mice exhibit decreased body length compared to wild-type mice but this difference becomes less significant after weaning
• postnatal growth retardation is not rescued by injection of growth hormone
• despite normal birth weights, mice exhibit a 50% reduction in body weight gain compared to wild-type mice regardless of strain background or fostering with wild-type mothers
• however, between 3 and 5 weeks of age growth rates are normal

behavior/neurological
• low doses of MK212 result in more pronounced hypoactivity than in wild-type mice, and food intake can be decreased by treatment with MK212 or mCPP
• low doses of SB242084, but not ketanserin or SB204741 (all HTR2C-specific antagonists) induce more hypolocomotion than in wild-type mice that cannot be reverted by treatment with haloperidol (a D2, D3 and D4 dopamine receptor antagonist) or R(+)-SCH23390 (a D1 dopamine receptor antagonist)
• mice exhibit hyperphagia
• however, food intake can be decreased by treatment with MK212
• mice are 2-fold less active than wild-type mice

adipose tissue
• adipose accumulation is lower than in wild-type mice




Genotype
MGI:3823069
ot7
Allelic
Composition
Htr2ctm1Knk/Y
Genetic
Background
C.Cg-Htr2ctm1Knk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Htr2ctm1Knk mutation (1 available); any Htr2c mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• despite normal birth weights, mice exhibit a 50% reduction in body weight gain compared to wild-type mice regardless of strain background or fostering with wild-type mothers





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory